References
Kellam, A. M. P. The Neuroleptic Malignant Syndrome, so-called. Brit. J. Psych. 1987: 150, 752–759.
Keck, K. E., Pope, H. G., McElroy, S. L. Frequency and presentation of Neuroleptic Malignant Syndrome: A prospective study. Am. J. Psych. 1987: 144, 1344–1346.
Levenson, J. L., Fisher, J. G. Long-term outcome after Neuroleptic Malignant Syndrome. J. Clin. Psychiatry. 1988: 49, 154–156.
Gelenberg, A. J., Bellinghausen, Wojcik, J. D., Falk, W. E., Farhadi, A. M. Patients with Neuroleptic Malignant Syndrome histories: what happens to them when they are re-hospitalised? J. Clin. Psychiatry, 1989: 50, 178–180.
Rosebush, P., Stewart, T. Twenty neuroleptic rechallenges after Neuroleptic Malignant Syndrome in 15 patients. J. Clin. Psychiatry. 1989: 50 295–298.
Freyne, ?., McCarthy, A. Neuroleptic Malignant Syndrome: nine cases. Ir. J. Med. Sci. 1988: 157, 321–323.
McCarthy, ?., Bourke, S., Fahy, J., Binchy, I., Fitzgerald, M. X. Fatal recurrence of Neuroleptic Malignant Syndrome. Brit. J. Psych. 1988: 152, 558–559.
Shulack, N. R. Sudden ‘exhaustive” death in excited patients. Psychi-atr. Q. 1944: 18, 3–12.
Fiebel, J. H., Schiffer, R. B. Sympathoadrenomedullary hyperactivity in the Neuroleptic Malignant Syndrome. Am. J. Psych. 1981: 138, 1115–1116.
Schidruk, M., Schachter, D. A role for catecholamines in the pathogenesis of Neuroleptic Malignant Syndrome. Can. J. Psych. 1986: 31, 66–69.
Rosebush, P., Stewart, T. A prospective analysis of 24 episodes of Neuroleptic Malignant Syndrome. Am. J. Psych. 1989: 146, 717–725.
Keck, P. E., Pope, H. E., Cohen, B. M., McElroy, S. L., Nierenberg, A. A. Risk factors for Neuroleptic Malignant Syndrome. Arch. Gen. Psychiatry. 1989: 46, 914–918.
Bayés de Luna, A., Coumel, P., Leclercq, J. F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am. Heart J. 1989: 117, 151–159.
Bellavere, F., Ferri, M., Guarini, L., Bay, G., Piccoli, A., Cardone, Fedale, D. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death. Br. Heart J. 1988: 59, 379–83.
May, D. C., Morris, S. W., Stewart, R. M., Fenton, B. J., Gaffney, F. A. Neuroleptic Malignant Syndrome: Response to Dantrolene Sodium. Ann. Int. Med. 1983: 98, 183–184.
Goldwasser, H. D., Hooper, J. F., Spears, N. M. Concomitant treatment of Neuroleptic Malignant Syndrome and psychosis. Brit. J. Psych. 1989: 154, 102–104.
Padgett, R., Lipman, E. Use of Neuroleptics after an episode of Neuroleptic Malignant Syndrome. Can. J. Psych. 1989: 34, 323–325.
Wells, A.J., Sommi, R.W., Crimson, M.L. Neuroleptic challenge after Neuroleptic Malignant Syndrome: Case report and literature review. Drug Intell. Clin. Pharm. 1988: 22, 475–480.
Shalev, A., Munitz, H. The Neuroleptic Malignant Syndrome: agent and host interaction. Acta Psychiatr. Scand. 1986: 73, 337–347.
Hermesh, H., Huberman, M., Rodvan, H., Kott, E. Single case study: recurrent Neuroleptic Malignant Syndrome due to tiapride and Haloperidol: the possible role of D-2 dopamine receptors. J. Nerv. Ment. Dis. 1984: 172, 692–695.
Olmsted, J. R. Neuroleptic Malignant Syndrome. Guidelines for treatment and reinstitution of treatment. South Med. J. 1988: 81, 888–891.
Susman, V. L., Addonizio, G. Re-introduction of Neuroleptic Malignant Syndrome by lithium. J. Clin. Psychopharmacol. 1987: 5, 339–341.
Caroff, S., Rosenberg, H., Gerber, J. Neuroleptic Malignant Syndrome and malignant hyperthermia. Lancet 1983: i, 244.
Addonizio, G., Susman, V. L. as a treatment alternative for patients with symptoms of Neuroleptic Malignant Syndrome. J. Clin, Psychiatry 1987: 48, 102–105.
Hermesh, H., Aizenberg, D., Lapidot, M., Munitz, M. The relationship between malignant hyperthermia and Neuroleptic Malignant Syndrome. Anaesthesiol. 1989: 70, 172–173.
Buckley, P., Carmody, E., Hutchinson, M. Wilson’s disease and the Neuroleptic Malignant Syndrome. Ir. J. Psycholog. Med. (in press, 1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buckley, P., Freyne, A., McCarthy, A. et al. Neuroleptic Malignant Syndrome — follow-up study. I.J.M.S. 160, 45–47 (1991). https://doi.org/10.1007/BF02947643
Issue Date:
DOI: https://doi.org/10.1007/BF02947643